skip to main content

    Updated Visitor Guidelines

 

MENU

 

Rogel Cancer Center establishes new Center of Excellence for Cancer Immunology and Immunotherapy

A new Center of Excellence for Cancer Immunology and Immunotherapy (CECII) within the Rogel Cancer Center will widen U-M’s scope of cancer immunological clinical research, positioning the institution as a global leader in this hot area of cancer research.

Overcoming a major barrier to developing liquid biopsies

An international consortium of labs tested nine different methods for RNA sequencing to understand and standardize the best methods for sequencing small RNAs. The goal was to create a process that could be reproduced from one lab to the next to the next.

Wicha awarded one of university’s highest honors

Max S. Wicha, a physician-scientist recognized internationally as a leader in cancer stem cell research and immuno-oncology, has been selected as the 2019 Henry Russel Lecturer, considered the University of Michigan’s highest honor for senior faculty members.

U-M ranked among the nation’s Best Hospitals for Pediatric Cancer

U.S. News & World Report ranked C.S. Mott Children’s Hospital No. 1 in Michigan and 24th in the nation for pediatric cancer care in its 2018 rankings of best children’s hospitals.

Richard and Susan Rogel to Receive AACI’s First Champion for Cures Award

The Association of American Cancer Institutes has established the Champion for Cures Award to recognize individuals who demonstrate significant leadership in supporting efforts to cure cancer and in inspiring others to do the same. The inaugural award will be presented to Richard and Susan Rogel, in recognition of their generous gift to the University of Michigan Rogel Cancer Center, which was renamed in their honor.

Integrative Therapies Guidelines Receive ASCO Endorsement

Many cancer patients use alternative medicine, including supplements, massage therapy, yoga, and acupuncture, while undergoing conventional cancer care. Such therapies are usually acceptable, but patients must discuss such therapies with their oncologist, because interactions may occur.

Metastatic Brain Tumors

Broad Range of Expertise for Metastatic Brain Tumors

For cancers that have spread to the brain, or metastasized, our team takes a very individualized approach to treatment. As one of only a few clinics dedicated to brain metastases in the country, we are able to work with our specialized primary cancer colleagues throughout the Rogel Cancer Center to offer patients continued support and treatment options.

Surgery

Innovation in Neurosurgical Options for Brain Tumors

The neurosurgical team at Rogel Cancer Center provides the most advanced surgical experience and expertise, using the most state-of-the-art techniques available.

Radiation and Radiosurgery

The Neuro-oncology program offers leading edge radiation and radiosurgery treatment

Our team of leading-edge radiation oncologists provide expert care for any type of brain or spinal tumors. For tumors that are well-localized in the brain, conformal radiation is often recommended. This is radiation delivered to the tumor and to a small surrounding area of brain, but it avoids other areas of the brain.

What we treat

The adult Neuro-oncology Program has a strong focus on cancerous and benign brain tumors. We treat patients with the following types of tumors:

Acoustic Neuroma

Astrocytoma:

  • Grade I – Pilocytic Astrocytoma
  • Grade II – Low-grade Astrocytoma
  • Grade III – Anaplastic Astrocytoma
  • Grade IV – Glioblastoma (GBM)

Chordoma

CNS Lymphoma

Pages